Ranexa har undersökts i en större studie på totalt 823 patienter med en genomsnittsålder på 64 år som haft angina pectoris i minst tre månader. ###>Ranexa has been studied in one main study including a total of 823 patients with an average age of 64 years who had had angina pectoris for at least three months.